IPP Bureau
Lonza appoints Daniel Palmacci as President of the Cell & Gene Division
By IPP Bureau - September 13, 2022
He takes over leadership of Cell & Gene from Jean-Christophe Hyvert, enabling Jean-Christophe to increase his focus on his role as President of the Biologics Division
AIIA launches 6-week long Ayurveda Day 2022 Programme
By IPP Bureau - September 13, 2022
The programme will see participation from various ministries of the Government of India with the aim of 3Js – Jan Sandesh, Jan Bhagidari, and Jan Aandolan.
AstraZeneca likely to see substantial Evusheld uptake in Japan, says GlobalData
By IPP Bureau - September 13, 2022
Japan’s Ministry of Health, Labour and Welfare (MHLW) has recently approved AstraZeneca's long-acting antibody combination “Evusheld” for the prevention ) and treatment of COVID-19.
Auretics Introduces its range of ayurvedic products
By IPP Bureau - September 13, 2022
This includes Madhurodhi, HBP Care & LBP Care for sugar & BP patients
Seagen, Astellas and Merck announce results of clinical trial investigating PADCEV with Keytruda for urothelial cancer
By IPP Bureau - September 13, 2022
Results demonstrated a 64.5% confirmed objective response rate in patients treated with investigational combination of enfortumab vedotin and pembrolizumab
We will vaccinate 100% of the animals by 2025: Narendra Modi
By IPP Bureau - September 13, 2022
The Prime Minister addressed a major problem that is affecting the income of farmers which is the diseases of animals and emphasised that in this direction India is working towards universal vaccination of animals
Merck’s pembrolizumab plus chemotherapy showed sustained survival benefit versus chemotherapy alone
By IPP Bureau - September 12, 2022
In first-line metastatic NSCLC, KEYTRUDA-based regimens have now shown a five-year survival benefit in four trials
Merck and Eisai present results from Phase 3 LEAP-002 Trial evaluating KEYTRUDA
By IPP Bureau - September 12, 2022
Findings to be featured in a late-breaking proffered paper session at European Society for Medical Oncology (ESMO) Congress 2022
Thalassemia Sickle Cell Society receives 200000th blood units
By IPP Bureau - September 12, 2022
Thalassemia and Sickle Cell Society (TSCS) always stands forefront in providing blood transfusion free of cost for Thalassemia Blood disorders patients
Zenara Pharma launches the first generic of Paxlovid for COVID-19 in India
By IPP Bureau - September 12, 2022
Pfizer’s Paxlovid is approved by US FDA for COVID treatment
WuXi STA opens a new sterile lipid nanoparticle formulation facility
By IPP Bureau - September 11, 2022
This new facility integrates multi-channel chip, micro-mixer system, and complex preparation system into a multi-channel micro-mixer core LNP manufacturing platform
Agilent named among top workplaces by Fortune in healthcare
By IPP Bureau - September 11, 2022
85% of Agilent employees who responded to the survey indicated that the company is a great place to work
Merck invests € 130 million + to strengthen manufacturing capabilities in France
By IPP Bureau - September 10, 2022
Investment further strengthens Merck's "Big 3," the key drivers for increasing Group sales to approximately € 25 billion by 2025
Lupin Launches Generic Suprep Bowel Prep Kit in US
By IPP Bureau - September 10, 2022
Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution (RLD Suprep Bowel Prep Kit) had estimated annual sales of US $202 mn in the US
Avery Pharmaceuticals starts commercial production of unit at Sanand
By IPP Bureau - September 10, 2022
The plant is a dedicated for manufacturing of Mouth dissolving strip.
